why choose us

First received: December 08, 2023

Clinical Trial: A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Advanced Cancer

Study Type: INTERVENTIONAL


Official Title: A Master Rollover Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

Brief Summary: This open-label, multicenter, rollover study will provide continued treatment for participants deriving benefit from different therapies received in studies sponsored by Daiichi Sankyo, Inc. (DS) or DS/Astra Zeneca (AZ)-sponsored study (eg.DS8201-A-J101, DS8201-A-U201, DS8201-A-U204, DS8201-A-U207, DS8201-A-U303).

Read more